<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>CE Marking - Comprehensive Guide</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: Aptos, 'Segoe UI', sans-serif;
            background: #f5f5f5;
            padding: 20px;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            background: white;
            padding: 50px 80px;
        }
        
        .title {
            font-size: 42px;
            font-weight: 700;
            color: #1E64C8;
            margin-bottom: 30px;
            text-align: center;
            padding-bottom: 20px;
            border-bottom: 3px solid #1E64C8;
        }
        
        .ce-grid {
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 18px;
            margin-bottom: 60px;
        }
        
        .ce-card {
            background: #f8f9fa;
            border-left: 4px solid #1E64C8;
            border-radius: 12px;
            padding: 20px;
            display: flex;
            flex-direction: column;
            transition: all 0.3s ease;
            min-height: 200px;
        }
        
        .ce-card:hover {
            background: #e8f2ff;
            transform: scale(1.02);
            box-shadow: 0 8px 20px rgba(30, 100, 200, 0.2);
        }
        
        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 12px;
        }
        
        .card-icon {
            width: 50px;
            height: 50px;
        }
        
        .card-title {
            font-size: 20px;
            font-weight: 700;
            color: #1E64C8;
            line-height: 1.2;
        }
        
        .card-content {
            flex: 1;
            display: flex;
            flex-direction: column;
            justify-content: center;
            gap: 8px;
        }
        
        .content-item {
            display: flex;
            align-items: center;
            gap: 10px;
            font-size: 15px;
            color: #555;
        }
        
        .item-bullet {
            width: 8px;
            height: 8px;
            background: #1E64C8;
            border-radius: 50%;
            flex-shrink: 0;
        }
        
        .special-card {
            grid-column: span 2;
            border-left: 4px solid #ffc107;
        }
        
        .special-card .card-title {
            color: #ffc107;
        }
        
        .special-card .item-bullet {
            background: #ffc107;
        }
        
        .ce-badge {
            position: absolute;
            top: 15px;
            right: 15px;
            width: 45px;
            height: 45px;
        }
        
        /* Detailed Sections */
        .detail-section {
            margin-top: 60px;
            padding-top: 40px;
            border-top: 2px solid #e0e0e0;
        }
        
        .detail-header {
            display: flex;
            align-items: center;
            gap: 20px;
            margin-bottom: 30px;
            padding: 25px;
            background: linear-gradient(135deg, #1E64C8 0%, #2980b9 100%);
            border-radius: 15px;
            color: white;
        }
        
        .detail-header.special {
            background: linear-gradient(135deg, #ffc107 0%, #ff9800 100%);
        }
        
        .detail-icon {
            width: 80px;
            height: 80px;
        }
        
        .detail-title {
            font-size: 32px;
            font-weight: 700;
        }
        
        .detail-content {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 30px;
            margin-bottom: 40px;
        }
        
        .content-box {
            background: #f8f9fa;
            padding: 25px;
            border-radius: 12px;
            border-left: 4px solid #1E64C8;
        }
        
        .content-box.special {
            border-left: 4px solid #ffc107;
        }
        
        .content-box h3 {
            color: #1E64C8;
            font-size: 20px;
            margin-bottom: 15px;
            font-weight: 600;
        }
        
        .content-box.special h3 {
            color: #ffc107;
        }
        
        .content-box p {
            color: #555;
            line-height: 1.6;
            margin-bottom: 12px;
        }
        
        .content-box ul {
            list-style: none;
            padding-left: 0;
        }
        
        .content-box li {
            padding: 8px 0;
            color: #555;
            position: relative;
            padding-left: 25px;
        }
        
        .content-box li:before {
            content: "‚Üí";
            position: absolute;
            left: 0;
            color: #1E64C8;
            font-weight: bold;
        }
        
        .content-box.special li:before {
            color: #ffc107;
        }
        
        .diagram {
            background: white;
            padding: 30px;
            border-radius: 12px;
            box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            margin-top: 20px;
        }
        
        .flowchart {
            display: flex;
            align-items: center;
            justify-content: space-between;
            gap: 15px;
            flex-wrap: wrap;
        }
        
        .flow-box {
            background: #e8f2ff;
            padding: 20px;
            border-radius: 10px;
            border: 2px solid #1E64C8;
            flex: 1;
            min-width: 150px;
            text-align: center;
            font-weight: 600;
            color: #1E64C8;
        }
        
        .flow-arrow {
            font-size: 24px;
            color: #1E64C8;
            font-weight: bold;
        }
        
        .classification-grid {
            display: grid;
            grid-template-columns: repeat(4, 1fr);
            gap: 15px;
            margin-top: 20px;
        }
        
        .class-box {
            background: linear-gradient(135deg, #e8f2ff 0%, #d1e7ff 100%);
            padding: 20px;
            border-radius: 10px;
            text-align: center;
            border: 2px solid #1E64C8;
        }
        
        .class-box h4 {
            color: #1E64C8;
            font-size: 18px;
            margin-bottom: 10px;
        }
        
        .class-box p {
            color: #555;
            font-size: 13px;
            line-height: 1.4;
        }
        
        .example-box {
            background: #fff9e6;
            border-left: 4px solid #ffc107;
            padding: 20px;
            border-radius: 8px;
            margin-top: 20px;
        }
        
        .example-box h4 {
            color: #ffc107;
            margin-bottom: 10px;
            font-size: 18px;
        }
        
        .example-box p {
            color: #666;
            line-height: 1.6;
        }
        
        .timeline {
            position: relative;
            padding-left: 40px;
            margin-top: 20px;
        }
        
        .timeline:before {
            content: '';
            position: absolute;
            left: 15px;
            top: 0;
            bottom: 0;
            width: 3px;
            background: #1E64C8;
        }
        
        .timeline-item {
            position: relative;
            padding: 15px 0;
        }
        
        .timeline-item:before {
            content: '';
            position: absolute;
            left: -32px;
            top: 20px;
            width: 15px;
            height: 15px;
            border-radius: 50%;
            background: #1E64C8;
            border: 3px solid white;
            box-shadow: 0 0 0 2px #1E64C8;
        }
        
        .timeline-item h4 {
            color: #1E64C8;
            font-size: 16px;
            margin-bottom: 5px;
        }
        
        .timeline-item p {
            color: #666;
            font-size: 14px;
            line-height: 1.5;
        }
        
        .highlight-box {
            background: linear-gradient(135deg, #ff6b6b 0%, #ee5a6f 100%);
            color: white;
            padding: 20px;
            border-radius: 12px;
            margin-top: 20px;
            text-align: center;
        }
        
        .highlight-box h4 {
            font-size: 20px;
            margin-bottom: 10px;
        }
        
        .highlight-box p {
            font-size: 15px;
            line-height: 1.6;
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="title">CE Marking Comprehensive Guide</div>
        
        <!-- Overview Section -->
        <div class="ce-grid">
            <div class="ce-card">
                <div class="card-header">
                    <svg class="card-icon" viewBox="0 0 100 100" xmlns="http://www.w3.org/2000/svg">
                        <rect x="20" y="25" width="60" height="55" rx="5" fill="none" stroke="#1E64C8" stroke-width="4"/>
                        <line x1="35" y1="40" x2="65" y2="40" stroke="#1E64C8" stroke-width="3"/>
                        <line x1="35" y1="52" x2="65" y2="52" stroke="#1E64C8" stroke-width="3"/>
                        <line x1="35" y1="64" x2="55" y2="64" stroke="#1E64C8" stroke-width="3"/>
                        <circle cx="75" cy="30" r="10" fill="#1E64C8"/>
                        <text x="75" y="36" text-anchor="middle" font-size="12" font-weight="bold" fill="white">EU</text>
                    </svg>
                    <div class="card-title">MDR<br>Requirements</div>
                </div>
                <div class="card-content">
                    <div class="content-item">
                        <div class="item-bullet"></div>
                        <span>Medical Device Regulation 2017/745</span>
                    </div>
                    <div class="content-item">
                        <div class="item-bullet"></div>
                        <span>Technical documentation</span>
                    </div>
                    <div class="content-item">
                        <div class="item-bullet"></div>
                        <span>Conformity assessment</span>
                    </div>
                </div>
            </div>
            
            <div class="ce-card">
                <div class="card-header">
                    <svg class="card-icon" viewBox="0 0 100 100" xmlns="http://www.w3.org/2000/svg">
                        <path d="M 50 15 L 85 40 L 75 75 L 25 75 L 15 40 Z" fill="none" stroke="#ff6b6b" stroke-width="4"/>
                        <rect x="35" y="35" width="10" height="35" rx="2" fill="#ff6b6b" opacity="0.3"/>
                        <rect x="50" y="45" width="10" height="25" rx="2" fill="#ff6b6b" opacity="0.6"/>
                        <rect x="65" y="55" width="10" height="15" rx="2" fill="#ff6b6b"/>
                        <text x="50" y="28" text-anchor="middle" font-size="14" font-weight="bold" fill="#ff6b6b">RISK</text>
                    </svg>
                    <div class="card-title">Risk<br>Classification</div>
                </div>
                <div class="card-content">
                    <div class="content-item">
                        <div class="item-bullet"></div>
                        <span>Class I, IIa, IIb, III</span>
                    </div>
                    <div class="content-item">
                        <div class="item-bullet"></div>
                        <span>Rule-based classification</span>
                    </div>
                    <div class="content-item">
                        <div class="item-bullet"></div>
                        <span>Notified Body involvement</span>
                    </div>
                </div>
            </div>
            
            <div class="ce-card">
                <div class="card-header">
                    <svg class="card-icon" viewBox="0 0 100 100" xmlns="http://www.w3.org/2000/svg">
                        <circle cx="50" cy="45" r="30" fill="none" stroke="#1E64C8" stroke-width="4"/>
                        <path d="M 35 45 L 47 57 L 65 35" fill="none" stroke="#28a745" stroke-width="5" stroke-linecap="round"/>
                        <rect x="30" y="70" width="40" height="15" rx="3" fill="#1E64C8"/>
                        <line x1="35" y1="77" x2="65" y2="77" stroke="white" stroke-width="2"/>
                        <line x1="35" y1="81" x2="55" y2="81" stroke="white" stroke-width="2"/>
                    </svg>
                    <div class="card-title">Clinical<br>Evaluation</div>
                </div>
                <div class="card-content">
                    <div class="content-item">
                        <div class="item-bullet"></div>
                        <span>Clinical data requirements</span>
                    </div>
                    <div class="content-item">
                        <div class="item-bullet"></div>
                        <span>Benefit-risk analysis</span>
                    </div>
                    <div class="content-item">
                        <div class="item-bullet"></div>
                        <span>Clinical evaluation report</span>
                    </div>
                </div>
            </div>
            
            <div class="ce-card">
                <div class="card-header">
                    <svg class="card-icon" viewBox="0 0 100 100" xmlns="http://www.w3.org/2000/svg">
                        <rect x="25" y="30" width="50" height="45" rx="5" fill="none" stroke="#1E64C8" stroke-width="4"/>
                        <circle cx="40" cy="50" r="6" fill="#1E64C8"/>
                        <circle cx="60" cy="50" r="6" fill="#1E64C8"/>
                        <path d="M 40 50 L 60 50" stroke="#1E64C8" stroke-width="3" stroke-dasharray="3,3"/>
                        <path d="M 35 62 L 40 67 L 50 57" fill="none" stroke="#28a745" stroke-width="3" stroke-linecap="round"/>
                        <circle cx="75" cy="25" r="8" fill="#1E64C8"/>
                        <text x="75" y="30" text-anchor="middle" font-size="12" font-weight="bold" fill="white">‚Üª</text>
                    </svg>
                    <div class="card-title">Post-market<br>Surveillance</div>
                </div>
                <div class="card-content">
                    <div class="content-item">
                        <div class="item-bullet"></div>
                        <span>PMS plan & reports</span>
                    </div>
                    <div class="content-item">
                        <div class="item-bullet"></div>
                        <span>Vigilance reporting</span>
                    </div>
                    <div class="content-item">
                        <div class="item-bullet"></div>
                        <span>PSUR requirements</span>
                    </div>
                </div>
            </div>
            
            <div class="ce-card special-card" style="position: relative;">
                <svg class="ce-badge" viewBox="0 0 100 100" xmlns="http://www.w3.org/2000/svg">
                    <circle cx="50" cy="50" r="40" fill="none" stroke="#ffc107" stroke-width="5"/>
                    <text x="50" y="42" text-anchor="middle" font-size="20" font-weight="bold" fill="#ffc107">UK</text>
                    <text x="50" y="62" text-anchor="middle" font-size="16" font-weight="bold" fill="#ffc107">CA</text>
                </svg>
                <div class="card-header">
                    <svg class="card-icon" viewBox="0 0 100 100" xmlns="http://www.w3.org/2000/svg">
                        <path d="M 20 40 L 50 20 L 80 40 L 80 75 L 20 75 Z" fill="none" stroke="#ffc107" stroke-width="4"/>
                        <rect x="40" y="50" width="20" height="25" fill="#ffc107" opacity="0.3"/>
                        <circle cx="50" cy="40" r="8" fill="#ffc107"/>
                        <path d="M 35 30 L 50 15 L 65 30" fill="none" stroke="#ffc107" stroke-width="3" stroke-linecap="round"/>
                    </svg>
                    <div class="card-title">UKCA Divergence</div>
                </div>
                <div class="card-content">
                    <div class="content-item">
                        <div class="item-bullet"></div>
                        <span>Post-Brexit UK requirements ‚Ä¢ Separate conformity assessment</span>
                    </div>
                    <div class="content-item">
                        <div class="item-bullet"></div>
                        <span>UK Approved Body vs. Notified Body ‚Ä¢ Dual marking considerations</span>
                    </div>
                </div>
            </div>
        </div>

        <!-- Detailed Section 1: MDR Requirements -->
        <div class="detail-section">
            <div class="detail-header">
                <svg class="detail-icon" viewBox="0 0 100 100" xmlns="http://www.w3.org/2000/svg">
                    <rect x="15" y="20" width="70" height="65" rx="5" fill="none" stroke="white" stroke-width="4"/>
                    <line x1="28" y1="35" x2="72" y2="35" stroke="white" stroke-width="3"/>
                    <line x1="28" y1="48" x2="72" y2="48" stroke="white" stroke-width="3"/>
                    <line x1="28" y1="61" x2="60" y2="61" stroke="white" stroke-width="3"/>
                    <line x1="28" y1="74" x2="65" y2="74" stroke="white" stroke-width="3"/>
                    <circle cx="80" cy="25" r="12" fill="white"/>
                    <text x="80" y="32" text-anchor="middle" font-size="14" font-weight="bold" fill="#1E64C8">EU</text>
                </svg>
                <div>
                    <div class="detail-title">1. MDR Requirements</div>
                    <p style="font-size: 16px; margin-top: 5px; opacity: 0.9;">Medical Device Regulation 2017/745 Framework</p>
                </div>
            </div>
            
            <div class="detail-content">
                <div class="content-box">
                    <h3>Regulatory Framework</h3>
                    <p>The Medical Device Regulation (MDR) 2017/745 replaced the Medical Device Directive (MDD) to ensure higher safety and performance standards for medical devices in the European market.</p>
                    <ul>
                        <li>Full application since May 26, 2021</li>
                        <li>Stricter requirements for clinical evidence</li>
                        <li>Enhanced post-market surveillance obligations</li>
                        <li>Increased transparency through EUDAMED database</li>
                    </ul>
                </div>
                
                <div class="content-box">
                    <h3>Technical Documentation</h3>
                    <p>Comprehensive technical documentation must demonstrate compliance with all applicable requirements of the MDR.</p>
                    <ul>
                        <li>Device description and specifications</li>
                        <li>Design and manufacturing information</li>
                        <li>Risk management documentation (ISO 14971)</li>
                        <li>Verification and validation reports</li>
                        <li>Clinical evaluation and safety data</li>
                    </ul>
                </div>
                
                <div class="content-box">
                    <h3>Conformity Assessment Procedures</h3>
                    <p>Manufacturers must follow specific conformity assessment routes based on device classification.</p>
                    <ul>
                        <li>Self-declaration for most Class I devices</li>
                        <li>Notified Body involvement for Class IIa, IIb, III</li>
                        <li>Quality management system certification</li>
                        <li>Technical documentation review</li>
                    </ul>
                </div>
                
                <div class="content-box">
                    <h3>Key Responsibilities</h3>
                    <p>Manufacturers must fulfill several ongoing obligations under MDR.</p>
                    <ul>
                        <li>Appoint an EU Authorized Representative (if outside EU)</li>
                        <li>Implement Quality Management System (ISO 13485)</li>
                        <li>Register devices in EUDAMED</li>
                        <li>Issue Declaration of Conformity (DoC)</li>
                        <li>Maintain technical documentation for 10+ years</li>
                    </ul>
                </div>
            </div>
            
            <div class="diagram">
                <h3 style="color: #1E64C8; margin-bottom: 20px; text-align: center;">MDR Compliance Pathway</h3>
                <div class="flowchart">
                    <div class="flow-box">Device Classification</div>
                    <div class="flow-arrow">‚Üí</div>
                    <div class="flow-box">Technical Documentation</div>
                    <div class="flow-arrow">‚Üí</div>
                    <div class="flow-box">Conformity Assessment</div>
                    <div class="flow-arrow">‚Üí</div>
                    <div class="flow-box">CE Marking</div>
                    <div class="flow-arrow">‚Üí</div>
                    <div class="flow-box">Market Access</div>
                </div>
            </div>
            
            <div class="example-box">
                <h4>üí° Practical Example</h4>
                <p>A manufacturer developing a blood glucose monitoring system (Class IIb) must prepare comprehensive technical documentation including clinical data, work with a Notified Body for conformity assessment, implement ISO 13485 quality management system, register the device in EUDAMED, and appoint an EU Authorized Representative before affixing the CE mark and entering the European market.</p>
            </div>
        </div>

        <!-- Detailed Section 2: Risk Classification -->
        <div class="detail-section">
            <div class="detail-header">
                <svg class="detail-icon" viewBox="0 0 100 100" xmlns="http://www.w3.org/2000/svg">
                    <path d="M 50 10 L 90 45 L 78 85 L 22 85 L 10 45 Z" fill="none" stroke="white" stroke-width="4"/>
                    <rect x="30" y="35" width="12" height="45" rx="2" fill="white" opacity="0.4"/>
                    <rect x="44" y="45" width="12" height="35" rx="2" fill="white" opacity="0.6"/>
                    <rect x="58" y="55" width="12" height="25" rx="2" fill="white" opacity="0.9"/>
                    <text x="50" y="25" text-anchor="middle" font-size="16" font-weight="bold" fill="white">RISK</text>
                </svg>
                <div>
                    <div class="detail-title">2. Risk Classification</div>
                    <p style="font-size: 16px; margin-top: 5px; opacity: 0.9;">Rule-Based Device Classification System</p>
                </div>
            </div>
            
            <div class="detail-content">
                <div class="content-box">
                    <h3>Classification Principles</h3>
                    <p>Medical devices are classified according to their intended purpose and the risks they pose to patients and users, following 22 classification rules in MDR Annex VIII.</p>
                    <ul>
                        <li>Duration of contact with the body</li>
                        <li>Degree of invasiveness</li>
                        <li>Local versus systemic effect</li>
                        <li>Whether the device is active or contains medicine</li>
                    </ul>
                </div>
                
                <div class="content-box">
                    <h3>Classification Rules</h3>
                    <p>The MDR contains 22 classification rules divided into four categories.</p>
                    <ul>
                        <li>Non-invasive devices (Rules 1-4)</li>
                        <li>Invasive devices (Rules 5-8)</li>
                        <li>Active devices (Rules 9-13)</li>
                        <li>Special rules (Rules 14-22)</li>
                    </ul>
                </div>
                
                <div class="content-box">
                    <h3>Notified Body Requirements</h3>
                    <p>Higher risk classes require third-party assessment by Notified Bodies.</p>
                    <ul>
                        <li>Class I: Generally self-certification</li>
                        <li>Class IIa: Notified Body for technical documentation</li>
                        <li>Class IIb: Notified Body for QMS and design examination</li>
                        <li>Class III: Most stringent Notified Body involvement</li>
                    </ul>
                </div>
                
                <div class="content-box">
                    <h3>Classification Impact</h3>
                    <p>Device classification determines regulatory requirements and time to market.</p>
                    <ul>
                        <li>Level of clinical evidence required</li>
                        <li>Conformity assessment procedures</li>
                        <li>Post-market surveillance obligations</li>
                        <li>Regulatory review timelines and costs</li>
                    </ul>
                </div>
            </div>
            
            <div class="diagram">
                <h3 style="color: #1E64C8; margin-bottom: 20px; text-align: center;">Medical Device Classification System</h3>
                <div class="classification-grid">
                    <div class="class-box" style="border-color: #28a745; background: linear-gradient(135deg, #d4edda 0%, #c3e6cb 100%);">
                        <h4 style="color: #28a745;">Class I</h4>
                        <p><strong>Low Risk</strong></p>
                        <p>Bandages, examination gloves, walking aids, wheelchairs</p>
                        <p style="margin-top: 10px; font-weight: 600;">Self-certification possible</p>
                    </div>
                    
                    <div class="class-box" style="border-color: #ffc107; background: linear-gradient(135deg, #fff3cd 0%, #ffeaa7 100%);">
                        <h4 style="color: #ffc107;">Class IIa</h4>
                        <p><strong>Medium Risk</strong></p>
                        <p>Hearing aids, dental fillings, ultrasound scanners</p>
                        <p style="margin-top: 10px; font-weight: 600;">Notified Body review</p>
                    </div>
                    
                    <div class="class-box" style="border-color: #fd7e14; background: linear-gradient(135deg, #ffe5d0 0%, #ffd4a8 100%);">
                        <h4 style="color: #fd7e14;">Class IIb</h4>
                        <p><strong>Medium-High Risk</strong></p>
                        <p>Blood bags, lung ventilators, X-ray machines</p>
                        <p style="margin-top: 10px; font-weight: 600;">Full Notified Body assessment</p>
                    </div>
                    
                    <div class="class-box" style="border-color: #dc3545; background: linear-gradient(135deg, #f8d7da 0%, #f5c6cb 100%);">
                        <h4 style="color: #dc3545;">Class III</h4>
                        <p><strong>High Risk</strong></p>
                        <p>Heart valves, implants, drug-eluting stents</p>
                        <p style="margin-top: 10px; font-weight: 600;">Most stringent assessment</p>
                    </div>
                </div>
            </div>
            
            <div class="highlight-box">
                <h4>‚ö†Ô∏è Critical Consideration</h4>
                <p>If multiple classification rules apply to a device, the strictest rule determines the final classification. Manufacturers should conduct thorough classification analysis early in development to understand regulatory requirements and plan accordingly.</p>
            </div>
        </div>

        <!-- Detailed Section 3: Clinical Evaluation -->
        <div class="detail-section">
            <div class="detail-header">
                <svg class="detail-icon" viewBox="0 0 100 100" xmlns="http://www.w3.org/2000/svg">
                    <circle cx="50" cy="45" r="35" fill="none" stroke="white" stroke-width="4"/>
                    <path d="M 32 45 L 45 58 L 68 32" fill="none" stroke="white" stroke-width="6" stroke-linecap="round"/>
                    <rect x="25" y="72" width="50" height="18" rx="3" fill="white"/>
                    <line x1="32" y1="81" x2="68" y2="81" stroke="#1E64C8" stroke-width="2"/>
                    <line x1="32" y1="86" x2="58" y2="86" stroke="#1E64C8" stroke-width="2"/>
                </svg>
                <div>
                    <div class="detail-title">3. Clinical Evaluation</div>
                    <p style="font-size: 16px; margin-top: 5px; opacity: 0.9;">Evidence-Based Safety and Performance Assessment</p>
                </div>
            </div>
            
            <div class="detail-content">
                <div class="content-box">
                    <h3>Clinical Evaluation Process</h3>
                    <p>A systematic and planned process to continuously generate, collect, analyze and assess clinical data pertaining to a device.</p>
                    <ul>
                        <li>Literature review and analysis</li>
                        <li>Equivalent device assessment</li>
                        <li>Clinical investigation data</li>
                        <li>Post-market clinical follow-up (PMCF)</li>
                    </ul>
                </div>
                
                <div class="content-box">
                    <h3>Clinical Data Requirements</h3>
                    <p>MDR Article 61 requires manufacturers to demonstrate compliance through clinical evidence.</p>
                    <ul>
                        <li>Pre-market clinical investigations where necessary</li>
                        <li>Scientific literature on similar devices</li>
                        <li>Post-market surveillance data</li>
                        <li>Registries and real-world evidence</li>
                        <li>Increased requirements for high-risk devices</li>
                    </ul>
                </div>
                
                <div class="content-box">
                    <h3>Benefit-Risk Analysis</h3>
                    <p>Comprehensive evaluation demonstrating that benefits outweigh residual risks.</p>
                    <ul>
                        <li>Identified risks and hazards</li>
                        <li>Residual risks after risk mitigation</li>
                        <li>Clinical benefits for intended purpose</li>
                        <li>Comparison with alternative treatments</li>
                        <li>Acceptability of benefit-risk ratio</li>
                    </ul>
                </div>
                
                <div class="content-box">
                    <h3>Clinical Evaluation Report (CER)</h3>
                    <p>Comprehensive document demonstrating conformity with relevant general safety and performance requirements.</p>
                    <ul>
                        <li>Device description and specifications</li>
                        <li>Clinical background and state of the art</li>
                        <li>Appraisal of clinical data</li>
                        <li>Analysis of benefit-risk profile</li>
                        <li>Conclusions and recommendations</li>
                    </ul>
                </div>
            </div>
            
            <div class="diagram">
                <h3 style="color: #1E64C8; margin-bottom: 20px; text-align: center;">Clinical Evaluation Lifecycle</h3>
                <div class="timeline">
                    <div class="timeline-item">
                        <h4>Stage 1: Planning</h4>
                        <p>Define scope, clinical evaluation plan, literature search strategy, and equivalence criteria if applicable.</p>
                    </div>
                    <div class="timeline-item">
                        <h4>Stage 2: Data Collection</h4>
                        <p>Gather clinical data from literature, clinical investigations, post-market data, and equivalent devices.</p>
                    </div>
                    <div class="timeline-item">
                        <h4>Stage 3: Analysis & Appraisal</h4>
                        <p>Critically analyze clinical data quality, relevance, and sufficiency to demonstrate safety and performance.</p>
                    </div>
                    <div class="timeline-item">
                        <h4>Stage 4: Report Generation</h4>
                        <p>Compile Clinical Evaluation Report (CER) with benefit-risk analysis and conclusions.</p>
                    </div>
                    <div class="timeline-item">
                        <h4>Stage 5: Continuous Update</h4>
                        <p>Regular updates through Post-Market Clinical Follow-up (PMCF) and periodic safety update reports.</p>
                    </div>
                </div>
            </div>
            
            <div class="example-box">
                <h4>üí° Practical Example</h4>
                <p>For a new orthopedic knee implant (Class III), the manufacturer must conduct clinical investigations with at least 5-year follow-up data, perform extensive literature reviews on similar implants, establish equivalence claims with supporting evidence, conduct PMCF studies to monitor long-term performance, and update the CER annually based on new data. The benefit-risk analysis must demonstrate superior or equivalent outcomes compared to existing gold-standard treatments.</p>
            </div>
        </div>

        <!-- Detailed Section 4: Post-Market Surveillance -->
        <div class="detail-section">
            <div class="detail-header">
                <svg class="detail-icon" viewBox="0 0 100 100" xmlns="http://www.w3.org/2000/svg">
                    <rect x="20" y="25" width="60" height="55" rx="5" fill="none" stroke="white" stroke-width="4"/>
                    <circle cx="38" cy="48" r="8" fill="white"/>
                    <circle cx="62" cy="48" r="8" fill="white"/>
                    <path d="M 38 48 L 62 48" stroke="white" stroke-width="3" stroke-dasharray="3,3"/>
                    <path d="M 32 62 L 38 68 L 50 56" fill="none" stroke="white" stroke-width="4" stroke-linecap="round"/>
                    <circle cx="82" cy="22" r="10" fill="white"/>
                    <text x="82" y="28" text-anchor="middle" font-size="14" font-weight="bold" fill="#1E64C8">‚Üª</text>
                </svg>
                <div>
                    <div class="detail-title">4. Post-Market Surveillance</div>
                    <p style="font-size: 16px; margin-top: 5px; opacity: 0.9;">Continuous Monitoring and Safety Management</p>
                </div>
            </div>
            
            <div class="detail-content">
                <div class="content-box">
                    <h3>PMS Plan & System</h3>
                    <p>Systematic process to actively collect and analyze data about the quality, safety, and performance of devices throughout their lifecycle.</p>
                    <ul>
                        <li>Define data collection methods and sources</li>
                        <li>Establish indicators and thresholds</li>
                        <li>Customer feedback and complaint handling</li>
                        <li>Systematic literature reviews</li>
                        <li>Integration with quality management system</li>
                    </ul>
                </div>
                
                <div class="content-box">
                    <h3>Vigilance Reporting</h3>
                    <p>Mandatory reporting of serious incidents and field safety corrective actions to competent authorities.</p>
                    <ul>
                        <li>Serious incidents: Report within 15 days</li>
                        <li>Trend reporting for non-serious incidents</li>
                        <li>Field Safety Notices (FSN) to users</li>
                        <li>Field Safety Corrective Actions (FSCA)</li>
                        <li>Reporting through EUDAMED</li>
                    </ul>
                </div>
                
                <div class="content-box">
                    <h3>PSUR Requirements</h3>
                    <p>Periodic Safety Update Reports (PSUR) provide a risk-benefit evaluation based on post-market data.</p>
                    <ul>
                        <li>Class IIa: At least every 2 years</li>
                        <li>Class IIb: At least annually</li>
                        <li>Class III: At least annually</li>
                        <li>Summary of PMS data and trends</li>
                        <li>Updated benefit-risk determination</li>
                    </ul>
                </div>
                
                <div class="content-box">
                    <h3>PMCF Activities</h3>
                    <p>Post-Market Clinical Follow-up is a continuous process to update clinical evaluation throughout device lifetime.</p>
                    <ul>
                        <li>PMCF plan as part of PMS plan</li>
                        <li>Proactive data collection through studies</li>
                        <li>Analysis of registries and databases</li>
                        <li>PMCF evaluation report</li>
                        <li>Mandatory for Class III and implantable devices</li>
                    </ul>
                </div>
            </div>
            
            <div class="diagram">
                <h3 style="color: #1E64C8; margin-bottom: 20px; text-align: center;">Post-Market Surveillance Cycle</h3>
                <svg viewBox="0 0 600 400" xmlns="http://www.w3.org/2000/svg" style="width: 100%; max-width: 600px; margin: 20px auto; display: block;">
                    <!-- Central Circle -->
                    <circle cx="300" cy="200" r="60" fill="#1E64C8" opacity="0.1" stroke="#1E64C8" stroke-width="3"/>
                    <text x="300" y="200" text-anchor="middle" font-size="16" font-weight="bold" fill="#1E64C8">PMS</text>
                    <text x="300" y="220" text-anchor="middle" font-size="14" fill="#1E64C8">System</text>
                    
                    <!-- Data Collection -->
                    <rect x="50" y="50" width="120" height="70" rx="8" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2"/>
                    <text x="110" y="75" text-anchor="middle" font-size="14" font-weight="bold" fill="#1E64C8">Data</text>
                    <text x="110" y="92" text-anchor="middle" font-size="13" fill="#555">Collection</text>
                    <text x="110" y="108" text-anchor="middle" font-size="11" fill="#666">‚Ä¢ Complaints</text>
                    
                    <!-- Analysis -->
                    <rect x="430" y="50" width="120" height="70" rx="8" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2"/>
                    <text x="490" y="75" text-anchor="middle" font-size="14" font-weight="bold" fill="#1E64C8">Analysis &</text>
                    <text x="490" y="92" text-anchor="middle" font-size="13" fill="#555">Evaluation</text>
                    <text x="490" y="108" text-anchor="middle" font-size="11" fill="#666">‚Ä¢ Trends</text>
                    
                    <!-- Reporting -->
                    <rect x="430" y="280" width="120" height="70" rx="8" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2"/>
                    <text x="490" y="305" text-anchor="middle" font-size="14" font-weight="bold" fill="#1E64C8">Reporting</text>
                    <text x="490" y="322" text-anchor="middle" font-size="13" fill="#555">& Updates</text>
                    <text x="490" y="338" text-anchor="middle" font-size="11" fill="#666">‚Ä¢ PSUR</text>
                    
                    <!-- Action -->
                    <rect x="50" y="280" width="120" height="70" rx="8" fill="#e8f2ff" stroke="#1E64C8" stroke-width="2"/>
                    <text x="110" y="305" text-anchor="middle" font-size="14" font-weight="bold" fill="#1E64C8">Corrective</text>
                    <text x="110" y="322" text-anchor="middle" font-size="13" fill="#555">Actions</text>
                    <text x="110" y="338" text-anchor="middle" font-size="11" fill="#666">‚Ä¢ FSCA</text>
                    
                    <!-- Arrows -->
                    <path d="M 170 85 L 240 160" stroke="#1E64C8" stroke-width="2" fill="none" marker-end="url(#arrowblue)"/>
                    <path d="M 360 160 L 430 85" stroke="#1E64C8" stroke-width="2" fill="none" marker-end="url(#arrowblue)"/>
                    <path d="M 490 120 L 490 280" stroke="#1E64C8" stroke-width="2" fill="none" marker-end="url(#arrowblue)"/>
                    <path d="M 430 315 L 360 240" stroke="#1E64C8" stroke-width="2" fill="none" marker-end="url(#arrowblue)"/>
                    <path d="M 240 240 L 170 315" stroke="#1E64C8" stroke-width="2" fill="none" marker-end="url(#arrowblue)"/>
                    <path d="M 110 280 L 110 120" stroke="#1E64C8" stroke-width="2" fill="none" marker-end="url(#arrowblue)"/>
                    
                    <defs>
                        <marker id="arrowblue" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto" markerUnits="strokeWidth">
                            <path d="M0,0 L0,6 L9,3 z" fill="#1E64C8"/>
                        </marker>
                    </defs>
                </svg>
            </div>
            
            <div class="highlight-box" style="background: linear-gradient(135deg, #1E64C8 0%, #2980b9 100%);">
                <h4>üìä Key Performance Indicators</h4>
                <p>Effective PMS systems track complaint rates, serious incident frequency, return rates, customer satisfaction scores, and trend analysis. Manufacturers must establish clear thresholds that trigger investigations and potential corrective actions to ensure ongoing device safety.</p>
            </div>
        </div>

        <!-- Detailed Section 5: UKCA Divergence -->
        <div class="detail-section">
            <div class="detail-header special">
                <svg class="detail-icon" viewBox="0 0 100 100" xmlns="http://www.w3.org/2000/svg">
                    <path d="M 15 45 L 50 15 L 85 45 L 85 80 L 15 80 Z" fill="none" stroke="white" stroke-width="4"/>
                    <rect x="35" y="52" width="30" height="28" fill="white" opacity="0.3"/>
                    <circle cx="50" cy="42" r="10" fill="white"/>
                    <path d="M 30 30 L 50 10 L 70 30" fill="none" stroke="white" stroke-width="3" stroke-linecap="round"/>
                    <text x="50" y="97" text-anchor="middle" font-size="16" font-weight="bold" fill="white">GB</text>
                </svg>
                <div>
                    <div class="detail-title">5. UKCA Divergence</div>
                    <p style="font-size: 16px; margin-top: 5px; opacity: 0.9;">Post-Brexit UK Regulatory Requirements</p>
                </div>
            </div>
            
            <div class="detail-content">
                <div class="content-box special">
                    <h3>Post-Brexit Landscape</h3>
                    <p>Following Brexit, the UK established its own regulatory framework requiring UKCA marking for devices placed on the Great Britain market.</p>
                    <ul>
                        <li>UKCA marking required since July 1, 2023</li>
                        <li>UK MDR 2002 (as amended) applies</li>
                        <li>Separate from EU MDR requirements</li>
                        <li>Northern Ireland follows EU rules (CE marking)</li>
                    </ul>
                </div>
                
                <div class="content-box special">
                    <h3>UK Approved Bodies</h3>
                    <p>UK Approved Bodies replace EU Notified Bodies for conformity assessment in Great Britain.</p>
                    <ul>
                        <li>UK Approved Body assessment required</li>
                        <li>Cannot use EU Notified Body certificates for UKCA</li>
                        <li>Re-certification may be necessary</li>
                        <li>MHRA maintains list of UK Approved Bodies</li>
                        <li>Different body numbering system</li>
                    </ul>
                </div>
                
                <div class="content-box special">
                    <h3>Dual Marking Strategy</h3>
                    <p>Manufacturers selling in both markets must consider dual compliance strategies.</p>
                    <ul>
                        <li>CE marking for EU/EEA market access</li>
                        <li>UKCA marking for Great Britain market</li>
                        <li>Both markings may appear on device</li>
                        <li>Separate technical documentation may be needed</li>
                        <li>Cost and timeline implications</li>
                    </ul>
                </div>
                
                <div class="content-box special">
                    <h3>Key Differences & Requirements</h3>
                    <p>While broadly aligned, some divergences exist between UK and EU requirements.</p>
                    <ul>
                        <li>UK Responsible Person instead of EU Authorized Rep</li>
                        <li>MHRA registration instead of EUDAMED</li>
                        <li>Different language requirements for IFU</li>
                        <li>Potential future regulatory divergence</li>
                        <li>Separate vigilance reporting systems</li>
                    </ul>
                </div>
            </div>
            
            <div class="diagram">
                <h3 style="color: #ffc107; margin-bottom: 20px; text-align: center;">Market Access Comparison</h3>
                <svg viewBox="0 0 700 300" xmlns="http://www.w3.org/2000/svg" style="width: 100%; max-width: 700px; margin: 20px auto; display: block;">
                    <!-- EU Market -->
                    <rect x="50" y="50" width="250" height="200" rx="12" fill="#e8f2ff" stroke="#1E64C8" stroke-width="3"/>
                    <text x="175" y="85" text-anchor="middle" font-size="20" font-weight="bold" fill="#1E64C8">EU/EEA Market</text>
                    <text x="175" y="120" text-anchor="middle" font-size="16" fill="#555">CE Marking</text>
                    <text x="175" y="145" text-anchor="middle" font-size="13" fill="#666">‚Ä¢ MDR 2017/745</text>
                    <text x="175" y="165" text-anchor="middle" font-size="13" fill="#666">‚Ä¢ Notified Body</text>
                    <text x="175" y="185" text-anchor="middle" font-size="13" fill="#666">‚Ä¢ EU Auth. Rep.</text>
                    <text x="175" y="205" text-anchor="middle" font-size="13" fill="#666">‚Ä¢ EUDAMED</text>
                    <circle cx="175" cy="230" r="15" fill="#1E64C8"/>
                    <text x="175" y="237" text-anchor="middle" font-size="14" font-weight="bold" fill="white">CE</text>
                    
                    <!-- UK Market -->
                    <rect x="400" y="50" width="250" height="200" rx="12" fill="#fff9e6" stroke="#ffc107" stroke-width="3"/>
                    <text x="525" y="85" text-anchor="middle" font-size="20" font-weight="bold" fill="#ffc107">UK (GB) Market</text>
                    <text x="525" y="120" text-anchor="middle" font-size="16" fill="#555">UKCA Marking</text>
                    <text x="525" y="145" text-anchor="middle" font-size="13" fill="#666">‚Ä¢ UK MDR 2002</text>
                    <text x="525" y="165" text-anchor="middle" font-size="13" fill="#666">‚Ä¢ UK Approved Body</text>
                    <text x="525" y="185" text-anchor="middle" font-size="13" fill="#666">‚Ä¢ UK Resp. Person</text>
                    <text x="525" y="205" text-anchor="middle" font-size="13" fill="#666">‚Ä¢ MHRA Registration</text>
                    <circle cx="525" cy="230" r="15" fill="#ffc107"/>
                    <text x="525" y="236" text-anchor="middle" font-size="12" font-weight="bold" fill="white">UK</text>
                    
                    <!-- Dividing line -->
                    <line x1="350" y1="50" x2="350" y2="250" stroke="#999" stroke-width="2" stroke-dasharray="5,5"/>
                    
                    <!-- Note -->
                    <text x="350" y="280" text-anchor="middle" font-size="12" fill="#666" font-style="italic">Different regulatory pathways - separate compliance required</text>
                </svg>
            </div>
            
            <div class="example-box">
                <h4>üí° Strategic Consideration</h4>
                <p>A medical device manufacturer targeting both EU and UK markets must work with both an EU Notified Body and a UK Approved Body, appoint separate legal representatives (EU Authorized Representative and UK Responsible Person), maintain dual registrations (EUDAMED and MHRA), and ensure labeling meets both CE and UKCA requirements. This dual compliance pathway significantly increases regulatory costs and complexity, requiring careful strategic planning for market entry.</p>
            </div>
            
            <div class="highlight-box" style="background: linear-gradient(135deg, #ffc107 0%, #ff9800 100%);">
                <h4>‚ö° Important Note</h4>
                <p>Northern Ireland remains aligned with EU regulations under the Northern Ireland Protocol. Devices for Northern Ireland market require CE marking and compliance with EU MDR, while Great Britain (England, Scotland, Wales) requires UKCA marking. Manufacturers must carefully consider their target markets when planning regulatory strategy.</p>
            </div>
        </div>

    </div>
</body>
</html>